GP1BA Gene von Willebrand Disease Platelet Type Genetic Test
Welcome to DNA Labs UAE, a leading genetic lab offering the GP1BA Gene von Willebrand Disease Platelet Type Genetic Test. This test helps diagnose von Willebrand disease platelet type (vWD-PT), a rare inherited bleeding disorder. We provide detailed information about the test, including its components, price, sample condition, report delivery time, method, test type, doctor, and test department.
Test Details
The GP1BA gene is associated with von Willebrand disease platelet type (vWD-PT), which is a rare inherited bleeding disorder. vWD-PT is caused by mutations in the GP1BA gene, which encodes the glycoprotein Ib alpha (GPIb) subunit of the von Willebrand factor (VWF) receptor on platelets.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of vWD-PT, NGS genetic testing can be used to identify mutations in the GP1BA gene, allowing for a diagnosis of the disorder.
By analyzing the DNA sequence of the GP1BA gene, NGS can detect specific mutations or variants that are associated with vWD-PT. This information can help healthcare professionals determine the underlying cause of the patient’s bleeding disorder and guide appropriate treatment and management strategies.
It is important to note that NGS genetic testing for vWD-PT is typically performed in specialized laboratories and is usually ordered by a healthcare provider with expertise in bleeding disorders. Genetic counseling is often recommended before and after genetic testing to help individuals understand the implications of the test results and make informed decisions about their healthcare.
Test Name
GP1BA Gene von Willebrand Disease Platelet Type Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Hematology
Doctor
Hematologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for GP1BA Gene von Willebrand Disease Platelet Type NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GP1BA Gene von Willebrand Disease Platelet Type NGS Genetic DNA Test gene GP1BA.
Thank you for considering DNA Labs UAE for your genetic testing needs. We strive to provide accurate and reliable results to help you and your healthcare provider make informed decisions about your health. Contact us today to schedule an appointment or for more information about our services.
Test Name | GP1BA Gene von Willebrand disease platelet type Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hematology |
Doctor | Hematologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GP1BA Gene von Willebrand disease platelet type NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GP1BA Gene von Willebrand disease platelet type NGS Genetic DNA Test gene GP1BA |
Test Details |
The GP1BA gene is associated with von Willebrand disease platelet type (vWD-PT), which is a rare inherited bleeding disorder. vWD-PT is caused by mutations in the GP1BA gene, which encodes the glycoprotein Ib alpha (GPIb) subunit of the von Willebrand factor (VWF) receptor on platelets. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of vWD-PT, NGS genetic testing can be used to identify mutations in the GP1BA gene, allowing for a diagnosis of the disorder. By analyzing the DNA sequence of the GP1BA gene, NGS can detect specific mutations or variants that are associated with vWD-PT. This information can help healthcare professionals determine the underlying cause of the patient’s bleeding disorder and guide appropriate treatment and management strategies. It is important to note that NGS genetic testing for vWD-PT is typically performed in specialized laboratories and is usually ordered by a healthcare provider with expertise in bleeding disorders. Genetic counseling is often recommended before and after genetic testing to help individuals understand the implications of the test results and make informed decisions about their healthcare. |